08-Jan-15 Korea’s domestic pharmaceutical R&D industry progressed strongly in 2014, securing approval of its 21st domestically developed drug, Liavax, and the entry of new medicines such as Kanarb and Supect onto the global market. In 2015 new Korean drugs for chemo-induced neutropenia, obesity and arthritis are expected to hit the market, as well as several new vaccines. [image: Business Korea]

18-Dec-14 In trade talks with the US, China has agreed to allow US medicines and medical devices into its markets more quickly. China agreed to “cut red tape” for imports of new and innovative pharmaceuticals and medical devices, said US Commerce Secretary Penny Pritzker. [image: CCTV America]

12-Dec-14 Non-communicable diseases were the cause of 78% of deaths in Latin America in 2008, estimated to rise to 84% by 2030. Obesity is at the heart of these deadly diseases, as a trigger for diabetes, high blood pressure, and high cholesterol. Mexico has the highest obesity growth rate in the world and the highest proportion of child obesity. [image: Global Health Intelligence]

10-Dec-14 Mergers and acquisitions in China’s healthcare sector rose to a record USD11.3 billion in the first 11 months of 2014, up 13% from a year earlier. A combination of ageing population and increasing affluence is driving the deal-making, coinciding with sweeping reforms by Chinese government. [image: Feucht Blog]

For more about China's healthcare sector, download our free 20-page whitepaper: China healthcare market opportunities

05-Dec-14 India produces a third of the world's medicines, mostly in the form of generic drugs. But more than 80% of the raw materials for these drugs are imported from China. That gives its neighbour a virtual monopoly over pricing and supply - so much so that there are now no domestic Indian producers of many essential medicines, a situation that worries the Indian government. [image: The Insider]